{"id":72155,"date":"2023-08-19T01:39:37","date_gmt":"2023-08-18T20:09:37","guid":{"rendered":"http:\/\/finservwealth.com\/bulk-deals-norges-bank-buys-stake-worth-rs-80-92-crore-in-concord-biotech-morgan-stanley-picks-up-1-24-in-repro-india\/"},"modified":"2023-08-19T01:39:37","modified_gmt":"2023-08-18T20:09:37","slug":"bulk-deals-norges-bank-buys-stake-worth-rs-80-92-crore-in-concord-biotech-morgan-stanley-picks-up-1-24-in-repro-india","status":"publish","type":"post","link":"https:\/\/finservwealth.com\/hi\/bulk-deals-norges-bank-buys-stake-worth-rs-80-92-crore-in-concord-biotech-morgan-stanley-picks-up-1-24-in-repro-india\/","title":{"rendered":"Bulk Deals: Norges Bank buys stake worth Rs 80.92 crore in Concord Biotech; Morgan Stanley picks up 1.24% in Repro India"},"content":{"rendered":"<p> Concord Biotech delivered stellar performance on its debut, rising 27 percent to settle at Rs 942.8 on the NSE, despite weakness in equity markets.<\/p><div id=\"finse-122069008\" class=\"finse-content finse-entity-placement\"><script async src=\"\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-9118214110898834\" crossorigin=\"anonymous\"><\/script><ins class=\"adsbygoogle\" style=\"display:block;\" data-ad-client=\"ca-pub-9118214110898834\" \ndata-ad-slot=\"\" \ndata-ad-format=\"auto\"><\/ins>\n<script> \n(adsbygoogle = window.adsbygoogle || []).push({}); \n<\/script>\n<\/div>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/buzzing-stocks\/bulk-deals-norges-bank-buys-stake-worth-rs-8092-croreconcord-biotech-morgan-stanley-picks124repro-india_17211401.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>\n<p>\u200b\u00a0Concord Biotech delivered stellar performance on its debut, rising 27 percent to settle at Rs 942.8 on the NSE, despite weakness in equity markets. Concord Biotech delivered stellar performance on its debut, rising 27 percent to settle at Rs 942.8 on the NSE, despite weakness in equity markets.\u00a0\u00a0Moneycontrol Latest News\u00a0<a href=\"https:\/\/www.moneycontrol.com\/news\/buzzing-stocks\/bulk-deals-norges-bank-buys-stake-worth-rs-8092-croreconcord-biotech-morgan-stanley-picks124repro-india_17211401.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a>\u00a0\u00a0<\/p>","protected":false},"excerpt":{"rendered":"<p><!-- wp:html --><\/p>\n<p> Concord Biotech delivered stellar performance on its debut, rising 27 percent to settle at Rs 942.8 on the NSE, despite weakness in equity markets.<\/p>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/buzzing-stocks\/bulk-deals-norges-bank-buys-stake-worth-rs-8092-croreconcord-biotech-morgan-stanley-picks124repro-india_17211401.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>\n<p>\u200b\u00a0Concord Biotech delivered stellar performance on its debut, rising 27 percent to settle at Rs 942.8 on the NSE, despite weakness in equity markets. Concord Biotech delivered stellar performance on its debut, rising 27 percent to settle at Rs 942.8 on the NSE, despite weakness in equity markets.\u00a0\u00a0Moneycontrol Latest News\u00a0<a href=\"https:\/\/www.moneycontrol.com\/news\/buzzing-stocks\/bulk-deals-norges-bank-buys-stake-worth-rs-8092-croreconcord-biotech-morgan-stanley-picks124repro-india_17211401.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a>\u00a0\u00a0<\/p>\n<p><!-- \/wp:html --> Concord Biotech delivered stellar performance on its debut, rising 27 percent to settle at Rs 942.8 on the NSE, despite weakness in equity markets.<\/p>","protected":false},"author":0,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"content-type":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"","neve_meta_content_width":0,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","_themeisle_gutenberg_block_has_review":false,"footnotes":""},"categories":[70],"tags":[],"class_list":["post-72155","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-latest-news"],"jetpack_featured_media_url":"https:\/\/www.moneycontrol.com\/news_image_files\/2023\/200x200\/S\/Stock-1_200.jpg","_links":{"self":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/72155","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/comments?post=72155"}],"version-history":[{"count":0,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/72155\/revisions"}],"wp:attachment":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/media?parent=72155"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/categories?post=72155"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/tags?post=72155"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}